Daniel A. Camardo
EVP and President, U.S., Horizon Therapeutics Public Ltd Co.
Companies
- Cue Biopharma, Inc.Board member Jun 8, 2026 to now1
- AthersysBoard member Feb 14, 2022 to Oct 6, 20232
- AthersysChief executive officer Feb 14, 2022 to Oct 6, 20232
- Horizon Therapeutics Public Ltd CoEVP and President, U.S. Aug 5, 2020 to Apr 5, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cue Biopharma, Inc. CUE21,800 shares4$364.3K at $16.71Jul 9, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 9, 2026Granted 21,800 shares of Cue Biopharma, Inc.4
- Oct 4, 2023Shares withheld for tax 19,993 shares at $0.44 of CIK 13681485
- Jul 5, 2023Shares withheld for tax 19,993 shares at $0.91 of CIK 13681486
- Apr 4, 2023Shares withheld for tax 19,993 shares at $1.00 of CIK 13681487
- Jan 4, 2023Shares withheld for tax 23,484 shares at $0.85 of CIK 13681488
- Nov 22, 2022Bought 100,000 shares at $0.55 of CIK 13681489
- Oct 4, 2022Granted 263,492 shares of CIK 136814810
- Mar 17, 2022Bought 132,800 shares at $0.77 of CIK 136814811
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCue Biopharma, Inc., Board member
- 2SEC EDGARAthersys, Board member
- 3
- 4
- 5SEC EDGARForm 4 filed Oct 6, 2023
- 6SEC EDGARForm 4 filed Jul 6, 2023
- 7SEC EDGARForm 4 filed Apr 5, 2023
- 8SEC EDGARForm 4 filed Jan 6, 2023
- 9SEC EDGARForm 4 filed Nov 22, 2022
- 10SEC EDGARForm 4 filed Oct 6, 2022
- 11SEC EDGARForm 4 filed Mar 17, 2022